(Q67488176)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1316075%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

title

Efficacy of lomefloxacin as compared to norfloxacin in the treatment of uncomplicated urinary tract infections in adults (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1316075%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

main subject

urinary tract infection

1 reference

A. Iravani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1316075

4 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1316075

4 December 2023

publication date

1 April 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1316075%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

6 April 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1316075

full work available at URL

4 December 2023

https://api.elsevier.com/content/article/PII:0002934392903142?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90314-2

https://api.elsevier.com/content/article/PII:0002934392903142?httpAccept=text/plain

4 December 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90314-2

American Journal of Medicine

4 December 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1316075%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1316075%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

issue

4A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1316075%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

page(s)

75S-81S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1316075%20AND%20SRC:MED&resulttype=core&format=json

In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents

14 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90314-2

In vitro and in vivo activity of NY-198, a new difluorinated quinolone

4 December 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90314-2

In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones

4 December 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90314-2

Comparative in vitro activity of lomefloxacin, a new difluoroquinolone.

4 December 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90314-2

Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses

4 December 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90314-2

Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions

4 December 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90314-2

Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora

4 December 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90314-2

Treatment of uncomplicated urinary tract infections with trimethoprim versus sulfisoxazole, with special reference to antibody-coated bacteria and fecal flora

4 December 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90314-2

Tissue penetration and clinical efficacy of enoxacin in urinary tract infections

4 December 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90314-2

Comparison of norfloxacin versus nalidixic acid in therapy of acute urinary tract infections

4 December 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90314-2

A double-blind, multicenter, comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of acute urinary tract infections in adult patients.

4 December 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90314-2

Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora

4 December 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90314-2

Comparative studies of fluoroquinolones in the treatment of urinary tract infections

4 December 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90314-2

Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections

4 December 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90314-2

Randomized, controlled trial of a 10-day course of amifloxacin versus trimethoprim-sulfamethoxazole in the treatment of acute, uncomplicated urinary tract infection. Amifloxacin Multi-Center Trial Group

4 December 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90314-2

Ofloxacin versus trimethoprim-sulfamethoxazole for treatment of acute cystitis

4 December 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90314-2

4 December 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1316075%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference